Bloomberg
@business
The first word in business news | Watch Live: | Newsletters: | Podcasts:
加入 April 2009
104 正在關注 10.5M 粉絲
Revolution Medicines secured US regulatory approval for its pancreatic cancer drug daraxonrasib, the first medicine to target one of the key molecular causes of the disease
